Disclosures for "Evaluation of a Small Molecule Genetic Medicine RTX-317 in Preclinical Models of Huntington's Disease"
-
Dr. Narayan has received personal compensation for serving as an employee of ReviR Therapeutics.
-
Dr. McMahon has received personal compensation for serving as an employee of ReviR Therapeutics .
-
Mr. Abid has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Zhang has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Salotti has received personal compensation for serving as an employee of ReviR Therapeutics.
-
Author has nothing to disclose
-
Mr. Lianoglou has received personal compensation for serving as an employee of ReviR Therapeutics.
-
Dr. Li has nothing to disclose.
-
Author has nothing to disclose
-
Dr. August has received personal compensation for serving as an employee of ReviR Therapeutics. Dr. August has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Charcot Marie Tooth Research Foundation. Dr. August has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AcuraStem. Dr. August has stock in Acurastem. Dr. August has stock in ReviR Therapeutics. The institution of Dr. August has received research support from CMTRF.